Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk
Autor: | Su-Ying Liang, Deborah A. Marshall, Kathryn A. Phillips, Judith M. E. Walsh, Nathalie A. Kulin, Stephanie L. Van Bebber |
---|---|
Rok vydání: | 2007 |
Předmět: |
Pharmacology
medicine.medical_specialty education.field_of_study medicine.diagnostic_test business.industry Population General Medicine Genetic Testing for Cancer Risk Test (assessment) Willingness to pay Family medicine Cancer screening medicine Molecular Medicine Personalized medicine Ordered logit business education Genetic testing |
Zdroj: | Personalized Medicine. 4:341-350 |
ISSN: | 1744-828X 1741-0541 |
DOI: | 10.2217/17410541.4.3.341 |
Popis: | Objectives: Personalized medicine using genetic information is increasing in cancer screening and treatment; however, little is known about perceived value of genetic testing for cancer risk in a general population. The objectives of this report are: to identify a general population’s willingness to pay for genetic testing that provids colorectal cancer risk information; examine whether screening intentions (likelihood of testing and test choice) change based on risk; and identify providers’ beliefs about patients’ perceived value. Methods: A survey of US general (n = 1087) and physician (n = 100) populations using the willingness-to-pay method was carried out. Physicians responded from the perspective of a typical patient. χ2 tests, t-tests and ordered logistic regression were used to examine factors associated with willingness to pay and intentions to be screened. Results: General population respondents’ average willingness to pay for a genetic test for colorectal cancer risk was US$150. Higher willingness to pay was significantly associated with being male, having higher income and education, having private health insurance and reporting a greater likelihood of getting colorectal cancer screening when due. Physicians’ beliefs about patients were different than general population responses: physicians believed patients would be willing to pay more (US$212; p |
Databáze: | OpenAIRE |
Externí odkaz: |